These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 22688794

  • 1. [NT-proBNP as a diagnostic marker in dogs with dyspnea and in asymptomatic dogs with heart murmur].
    Haßdenteufel E, Kresken JG, Henrich E, Hildebrandt N, Schneider C, Stosic A, Schneider M.
    Tierarztl Prax Ausg K Kleintiere Heimtiere; 2012; 40(3):171-9. PubMed ID: 22688794
    [Abstract] [Full Text] [Related]

  • 2. N-Terminal Pro-B-Type Natriuretic Peptide and Phonocardiography in Differentiating Innocent Cardiac Murmurs from Congenital Cardiac Anomalies in Asymptomatic Puppies.
    Marinus SM, van Engelen H, Szatmári V.
    J Vet Intern Med; 2017 May; 31(3):661-667. PubMed ID: 28316101
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of circulating amino terminal-pro-B-type natriuretic peptide concentration in dogs with respiratory distress attributable to congestive heart failure or primary pulmonary disease.
    Fine DM, DeClue AE, Reinero CR.
    J Am Vet Med Assoc; 2008 Jun 01; 232(11):1674-9. PubMed ID: 18518809
    [Abstract] [Full Text] [Related]

  • 4. [Personal experience with determination of NT-proBNP in clinical practice].
    Stejskal D, Oral I, Lacnák B, Juráková R, Horalík D, Adamovská S, Prosková J, Hrabovská I, Ozanová G.
    Vnitr Lek; 2003 Feb 01; 49(2):121-6. PubMed ID: 12728579
    [Abstract] [Full Text] [Related]

  • 5. Relationship of plasma N-terminal pro-brain natriuretic peptide concentrations to heart failure classification and cause of respiratory distress in dogs using a 2nd generation ELISA assay.
    Fox PR, Oyama MA, Hezzell MJ, Rush JE, Nguyenba TP, DeFrancesco TC, Lehmkuhl LB, Kellihan HB, Bulmer B, Gordon SG, Cunningham SM, MacGregor J, Stepien RL, Lefbom B, Adin D, Lamb K.
    J Vet Intern Med; 2015 Jan 01; 29(1):171-9. PubMed ID: 25308881
    [Abstract] [Full Text] [Related]

  • 6. Utility of plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) to distinguish between congestive heart failure and non-cardiac causes of acute dyspnea in cats.
    Fox PR, Oyama MA, Reynolds C, Rush JE, DeFrancesco TC, Keene BW, Atkins CE, Macdonald KA, Schober KE, Bonagura JD, Stepien RL, Kellihan HB, Nguyenba TP, Lehmkuhl LB, Lefbom BK, Moise NS, Hogan DF.
    J Vet Cardiol; 2009 May 01; 11 Suppl 1():S51-61. PubMed ID: 19394287
    [Abstract] [Full Text] [Related]

  • 7. Clinical utility of serum N-terminal pro-B-type natriuretic peptide concentration for identifying cardiac disease in dogs and assessing disease severity.
    Oyama MA, Fox PR, Rush JE, Rozanski EA, Lesser M.
    J Am Vet Med Assoc; 2008 May 15; 232(10):1496-503. PubMed ID: 18479239
    [Abstract] [Full Text] [Related]

  • 8. Effect of azotemia on serum N-terminal proBNP concentration in dogs with normal cardiac function: a pilot study.
    Schmidt MK, Reynolds CA, Estrada AH, Prosek R, Maisenbacher HW, Sleeper MM, Oyama MA.
    J Vet Cardiol; 2009 May 15; 11 Suppl 1():S81-6. PubMed ID: 19394913
    [Abstract] [Full Text] [Related]

  • 9. Multicenter evaluation of plasma N-terminal probrain natriuretic peptide (NT-pro BNP) as a biochemical screening test for asymptomatic (occult) cardiomyopathy in cats.
    Fox PR, Rush JE, Reynolds CA, Defrancesco TC, Keene BW, Atkins CE, Gordon SG, Schober KE, Bonagura JD, Stepien RL, Kellihan HB, Macdonald KA, Lehmkuhl LB, Nguyenba TP, Sydney Moise N, Lefbom BK, Hogan DF, Oyama MA.
    J Vet Intern Med; 2011 May 15; 25(5):1010-6. PubMed ID: 21985136
    [Abstract] [Full Text] [Related]

  • 10. Assessment of serum N-terminal pro-B-type natriuretic peptide concentration for differentiation of congestive heart failure from primary respiratory tract disease as the cause of respiratory signs in dogs.
    Oyama MA, Rush JE, Rozanski EA, Fox PR, Reynolds CA, Gordon SG, Bulmer BJ, Lefbom BK, Brown BA, Lehmkuhl LB, Prosek R, Lesser MB, Kraus MS, Bossbaly MJ, Rapoport GS, Boileau JS.
    J Am Vet Med Assoc; 2009 Dec 01; 235(11):1319-25. PubMed ID: 19951101
    [Abstract] [Full Text] [Related]

  • 11. The cardiac biomarker NT-proBNP is increased in dogs with azotemia.
    Raffan E, Loureiro J, Dukes-McEwan J, Fonfara S, James R, Swift S, Bexfield N, Herrtage ME, Archer J.
    J Vet Intern Med; 2009 Dec 01; 23(6):1184-9. PubMed ID: 19709357
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of plasma N-terminal pro-B-type natriuretic peptide concentrations in dogs with and without cardiac disease.
    Ettinger SJ, Farace G, Forney SD, Frye M, Beardow A.
    J Am Vet Med Assoc; 2012 Jan 15; 240(2):171-80. PubMed ID: 22217025
    [Abstract] [Full Text] [Related]

  • 13. Plasma N-terminal pro-brain natriuretic peptide concentrations before and after pericardiocentesis in dogs with cardiac tamponade secondary to spontaneous pericardial effusion.
    Baumwart RD, Hanzlicek AS, Lyon SD, Lee PM.
    J Vet Cardiol; 2017 Oct 15; 19(5):416-420. PubMed ID: 28988688
    [Abstract] [Full Text] [Related]

  • 14. NT-proBNP, NT-proANP and cTnI concentrations in dogs with pre-capillary pulmonary hypertension.
    Kellihan HB, Mackie BA, Stepien RL.
    J Vet Cardiol; 2011 Sep 15; 13(3):171-82. PubMed ID: 21835711
    [Abstract] [Full Text] [Related]

  • 15. Utility of N-terminal pro-brain natriuretic peptide for assessing hemodynamic significance of patent ductus arteriosus in dogs undergoing ductal repair.
    Hariu CD, Saunders AB, Gordon SG, Norby B, Miller MW.
    J Vet Cardiol; 2013 Sep 15; 15(3):197-204. PubMed ID: 23933478
    [Abstract] [Full Text] [Related]

  • 16. Utility of measuring plasma N-terminal pro-brain natriuretic peptide in detecting hypertrophic cardiomyopathy and differentiating grades of severity in cats.
    Wess G, Daisenberger P, Mahling M, Hirschberger J, Hartmann K.
    Vet Clin Pathol; 2011 Jun 15; 40(2):237-44. PubMed ID: 21434959
    [Abstract] [Full Text] [Related]

  • 17. The diagnostic relevance of NT-proBNP and proANP 31-67 measurements in staging of myxomatous mitral valve disease in dogs.
    Wolf J, Gerlach N, Weber K, Klima A, Wess G.
    Vet Clin Pathol; 2013 Jun 15; 42(2):196-206. PubMed ID: 23614733
    [Abstract] [Full Text] [Related]

  • 18. Assessment of circulating N-terminal pro B-type natriuretic peptide concentration to differentiate between cardiac from noncardiac causes of pleural effusion in cats.
    Hassdenteufel E, Henrich E, Hildebrandt N, Stosic A, Schneider M.
    J Vet Emerg Crit Care (San Antonio); 2013 Jun 15; 23(4):416-22. PubMed ID: 23859335
    [Abstract] [Full Text] [Related]

  • 19. N-terminal pro-B-type natriuretic peptide and its relationship with cardiac function in adults with congenital heart disease.
    Eindhoven JA, van den Bosch AE, Ruys TP, Opić P, Cuypers JA, McGhie JS, Witsenburg M, Boersma E, Roos-Hesselink JW.
    J Am Coll Cardiol; 2013 Sep 24; 62(13):1203-12. PubMed ID: 23916937
    [Abstract] [Full Text] [Related]

  • 20. Plasma N-terminal pro-B-type natriuretic peptide concentration in healthy retired racing Greyhounds.
    Couto KM, Iazbik MC, Marín LM, Zaldivar-López S, Beal MJ, Gómez Ochoa P, Couto CG.
    Vet Clin Pathol; 2015 Sep 24; 44(3):405-9. PubMed ID: 25982692
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.